Addressing a Key Metabolic Component of PCOS: Insulin
<p id="p1">This chapter addresses insulin - a key metabolic component of polycystic ovary syndrome (PCOS), that manifests as insulin resistance and/or hyperinsulinemia, which are prevalent in 65–95% of women with this complex condition. Insulin, insulin resistance, hyperinsulinemia, markers of...
Guardado en:
| Autores principales: | , |
|---|---|
| Formato: | Capítulo de libro |
| Lenguaje: | inglés |
| Publicado: |
IntechOpen
2025
|
| Materias: | |
| Acceso en línea: | https://www.intechopen.com/chapters/1222367 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| Sumario: | <p id="p1">This chapter addresses insulin - a key metabolic component of polycystic ovary syndrome (PCOS), that manifests as insulin resistance and/or hyperinsulinemia, which are prevalent in 65–95% of women with this complex condition. Insulin, insulin resistance, hyperinsulinemia, markers of insulin, and common health conditions associated with their pathophysiology are reviewed. The chapter also concentrates on nutrition as a viable, effective, evidence-based lifestyle option. Common nutritional approaches and the impact they have are presented. A low-insulin lifestyle approach is discussed as an effective intervention for PCOS management. Finally, this chapter presents research that supports the efficacy of a low-insulin lifestyle. Addressing this key metabolic dysfunction is essential for reducing comorbidities and improving the overall quality of health and quality of life in those with PCOS.</p> |
|---|---|
| ISBN: | 978-1-83635-334-8 |
| DOI: | 10.5772/intechopen.1010981 |